1,471
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

QT dispersion and P wave dispersion in schizophrenia

ORCID Icon, ORCID Icon & ORCID Icon
Pages 538-543 | Received 27 Feb 2018, Accepted 01 May 2018, Published online: 14 May 2018

References

  • Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. Br Med J. 2013;346:f2539. doi: 10.1136/bmj.f2539
  • Popovic D, Benabarre A, Crespo JM, et al. Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014;130(6):418–426. doi: 10.1111/acps.12332
  • Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatr. 2015;72(4):334–341. doi: 10.1001/jamapsychiatry.2014.2502
  • Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115–1121. doi: 10.1016/j.ahj.2005.02.007
  • Riordan HJ, Antonini P, Murphy MF. Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Am Health Drug Benefits. 2011;4(5):292–302.
  • Bobes J, Arango C, Garcia-Garcia M, et al. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res. 2010;119(1-3):101–109. doi: 10.1016/j.schres.2010.02.1030
  • Samele C, Patel M, Boydell J, et al. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol. 2007;42(2):117–124. doi: 10.1007/s00127-006-0135-2
  • Daumit GL, Goldberg RW, Anthony C, et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis. 2005;193(10):641–646. doi: 10.1097/01.nmd.0000180737.85895.60
  • McCreadie RG, Scottish G. Schizophrenia lifestyle, diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatr. 2003;183:534–539. doi: 10.1192/bjp.183.6.534
  • Grundy SM, Brewer HB, Cleeman Jr JI. et al. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438. doi: 10.1161/01.CIR.0000111245.75752.C6
  • Huang TL, Chen JF. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan. Schizophr Res. 2005;80(1):55–59. doi: 10.1016/j.schres.2005.05.001
  • Schocken K. The analysis of the normal QT interval. Exp Med Surg. 1955;13(3):258–260.
  • Aytemir K, Ozer N, Atalar E, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23(7):1109–1112. doi: 10.1111/j.1540-8159.2000.tb00910.x
  • Vloka ME, Steinberg JS. QT dispersion: current and future clinical role. J Invasive Cardiol. 1996;8(8):363–369.
  • Nahshoni E, Gur S, Marom S, et al. QT dispersion in patients with social phobia. J Affect Disord. 2004;78(1):21–26. doi: 10.1016/S0165-0327(02)00052-6
  • Piccirillo G, Viola E, Bucca C, et al. QT interval dispersion and autonomic modulation in subjects with anxiety. J Lab Clin Med. 1999;133(5):461–468. doi: 10.1016/S0022-2143(99)90023-9
  • Izci F, Hocagil H, Izci S, et al. P-wave and QT dispersion in patients with conversion disorder. Ther Clin Risk Manag. 2015;11:475–480. doi: 10.2147/TCRM.S81852
  • Takimoto Y, Yoshiuchi K, Akabayashi A. Effect of mood states on QT interval and QT dispersion in eating disorder patients. Psychiatr Clin Neurosci. 2008;62(2):185–189. doi: 10.1111/j.1440-1819.2008.01753.x
  • Atmaca M, Yavuzkir M, Izci F, et al. QT wave dispersion in patients with panic disorder. Neurosci Bull. 2012;28(3):247–252. doi: 10.1007/s12264-012-1237-3
  • Yavuzkir M, Atmaca M, Dagli N, et al. P-wave dispersion in panic disorder. Psychosom Med. 2007;69(4):344–347. doi: 10.1097/PSY.0b013e3180616900
  • Yavuzkir MF, Atmaca M, Gurok MG, et al. P wave dispersion in obsessive-compulsive disorder. Indian J Psychiatry. 2015;57(2):196–199. doi: 10.4103/0019-5545.158193
  • Robyns T, Willems R, Vandenberk B, et al. Individualized corrected QT interval is superior to QT interval corrected using the Bazett formula in predicting mutation carriage in families with long QT syndrome. Heart Rhythm. 2017;14(3):376–382. doi: 10.1016/j.hrthm.2016.11.034
  • Szabo Z, Kakuk G, Fulop T, et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant. 2002;17(9):1634–1638. doi: 10.1093/ndt/17.9.1634
  • Manu P, Correll CU, Wampers M, et al. Markers of inflammation in schizophrenia: association vs. causation. World Psychiatr. 2014;13(2):189–192. doi: 10.1002/wps.20117
  • Chadda RK, Ramshankar P, Deb KS, et al. Metabolic syndrome in schizophrenia: differences between antipsychotic-naive and treated patients. J Pharmacol Pharmacother. 2013;4(3):176–186. doi: 10.4103/0976-500X.114596
  • Mitchell AJ, Vancampfort D, De Herdt A, et al. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull. 2013;39(2):295–305. doi: 10.1093/schbul/sbs082
  • Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatr. 2003;160(2):284–289. doi: 10.1176/appi.ajp.160.2.284
  • Emul M, Dalkiran M, Coskun O, et al. P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration. Pharmacol Res. 2009;60(5):369–372. doi: 10.1016/j.phrs.2009.07.008
  • Jackson T, Ditmanson L, Phibbs B. Torsade de pointes and low-dose oral haloperidol. Arch Intern Med. 1997;157(17):2013–2015. doi: 10.1001/archinte.1997.00440380123013
  • Lawrence KR, Nasraway SA. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy. 1997;17(3):531–537.
  • Krahenbuhl S, Sauter B, Kupferschmidt H, et al. Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication. Am J Med Sci. 1995;309(6):315–316. doi: 10.1097/00000441-199506000-00003
  • Welch R, Chue P. Antipsychotic agents and QT changes. J Psychiatr Neurosci. 2000;25(2):154–160.
  • Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355(9209):1048–1052. doi: 10.1016/S0140-6736(00)02035-3
  • Nahshoni E, Spitzer S, Berant M, et al. QT interval and dispersion in very young children treated with antipsychotic drugs: a retrospective chart review. J Child Adolesc Psychopharmacol. 2007;17(2):187–194. doi: 10.1089/cap.2007.0061
  • Nahshoni E, Manor N, Bar F, et al. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy. Eur Neuropsychopharmacol. 2004;14(2):121–125. doi: 10.1016/S0924-977X(03)00098-1